Discovery of a novel class of triazolones as checkpoint kinase inhibitors–hit to lead exploration.

Oza V., Ashwell S., Brassil P., Breed J., Deng C., Ezhuthachan J., Haye H., Horn C., Janetka J., Lyne P., Newcombe N., Otterbien L., Pass M., Read J., Roswell S., Su M., Toader D., Yu D., Yu Y., Valentine A., Webborn P., White A., Zabludoff S., and Zheng X.
Discovery of a novel class of triazolones as checkpoint kinase inhibitors–hit to lead exploration.
Bioorg Med Chem Lett. 20(17):5133-8. doi: 10.1016/j.bmcl.2010.07.015. (2010) (Abstract)